Medicare AdvantageCoverageMedium impact
MA11.052f, Ablation of Lung Tumors
Independence Blue Cross·Pulmonology, Oncology, Cardiothoracic Surgery +1 more·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.052f for ablation of lung tumors has been updated, effective January 1, 2026. This fresh policy supersedes previous guidance for lung tumor ablation procedures under Medicare Advantage plans.
Action Required
By January 1, 2026: Billing team must review updated policy MA11.052f for lung tumor ablation procedures. Access the full policy details at the provided URL to understand any changes to coverage criteria, prior authorization requirements, or documentation standards for Medicare Advantage patients requiring lung tumor ablation.